AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B
Bio Pharma Dive
DECEMBER 12, 2023
The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.
Pfizer, BioNTech bet mRNA can make a better shingles vaccine
Bio Pharma Dive
JANUARY 5, 2022
The pharma company, already partnered with BioNTech on vaccines for COVID-19 and influenza, will pay $225 million upfront to further expand its work with the German biotech.
Vaccination 
321
321 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring
BioSpace
APRIL 18, 2024
French healthcare and pharma company Sanofi will terminate an undisclosed number of positions in its U.S. vaccines commercial unit in an effort to streamline the strategic sales structure.
Vaccination 110
110 
World’s Top 10 Pharma Companies (By 2023 Revenue)
XTalks
MAY 29, 2024
The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.
mRNA Vaccine Manufacturing Comes to Africa
BioSpace
SEPTEMBER 26, 2023
The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it will start manufacturing vaccines in Africa.
Manufacturing 130
130 
Vaccine issues already?
World of DTC Marketing
DECEMBER 9, 2020
Pfizer is having supplier issues, some people who received the vaccine are reporting side effects like Bell’s Palsy. In the meantime this administration is patting itself on the back for the quick development of vaccines. What assurances does the public have that every dose of vaccine is made to the highest quality standards?
Vaccination 272
272 
Is it time for vaccination mandates?
World of DTC Marketing
JULY 20, 2021
29 percent of Americans said they were unlikely to get vaccinated — up from 24 percent three months earlier. Most workers do not want their own employer to require vaccination, including the vast majority of unvaccinated workers (92%). Yet even as evidence grows that vaccines are safe and effective, resistance to them is also growing.
Vaccination 309
309 
Covid vaccine profits and the strain on supply channels
World of DTC Marketing
JANUARY 8, 2021
SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. So far the winners are Pfizer and Moderna.
Vaccination 266
266 
Pharma failing the moral ethics of Covid vaccines
World of DTC Marketing
DECEMBER 7, 2021
LEAD IN: Pharma companies are a business and have the right to make money but at what cost and how much is enough? The world’s makers of Covid-19 vaccines—saw over $10 billion in new wealth, with the Moderna’s CEO alone adding over $800 million to his fortune. Is this acceptable?
Vaccination 222
222 
COVID 19 vaccine means big money and greed
World of DTC Marketing
JULY 28, 2020
QUICK READ : Pharma had a chance to earn some goodwill with a very skeptical public but it’s become obvious that the rush to develop a vaccine is about profit, executive stock, and Wall Street despite potential huge investments from the government. Moderna, a 10-year-old vaccine developer based in Cambridge, Mass.,
Vaccination 181
181 
Profiteering off a Covid vaccine
World of DTC Marketing
MARCH 25, 2021
SUMMARY: Johnson & Johnson and AstraZeneca publicly committed to not profiting off their products during the pandemic; Pfizer and Moderna made no such pledge and are already planning ways to make more money from their Covid vaccines. The vaccines are already poised to be some of the most lucrative drugs of all time.
Vaccination 188
188 
Pharma Companies Strike Deals to Deliver Millions of COVID-19 Vaccines by 2021
BioSpace
OCTOBER 28, 2020
BioSpace provides an up-to-date overview of these deals and the projected COVID-19 vaccine doses each company plans to have within the next couple of years.
Pharma Companies 105
105 
The waiver on COVID vaccine patents is not about the vaccine
World of DTC Marketing
MAY 21, 2021
IT’S FRIDAY: The Biden administration’s decision to support a temporary waiver of Covid-19 vaccine patents prompted instant and false outrage in pharma. Pharma is afraid the move could compromise future drug profits, so they need to fight hard now to ensure it doesn’t happen again.
Vaccination 219
219 
Pfizer, marking fast research pace, starts key trial of RSV vaccine
Bio Pharma Dive
SEPTEMBER 2, 2021
The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.
Pharma Companies 285
285 
Pfizer positions COVID vaccine as a yearly booster shot
World of DTC Marketing
APRIL 2, 2021
QUICK READ: Pfizer is already positioning their Covid vaccine as a yearly maintenance shot. Make no mistake; the drug companies will make a lot of money from these vaccines while they continue to hide profits offshore. ( New York Times) If you listen to the stated intentions of vaccine producers.
Vaccination 193
193 
BioNTech mobile mRNA vaccine labs reach Rwanda
Medical Xpress
MARCH 13, 2023
Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.
Vaccination 72
72 
Pharma’s vaccine pushback “too late”?
World of DTC Marketing
SEPTEMBER 7, 2020
IN SHORT: It may be too late for pharma to persuade the public that any COVID-19 vaccine is safe and effective as the FDA continues to be a political baseball in play. It’s now being reported that up to one-third of people may not get a COVID-19 vaccination when one become available. Now comes the power of social media.
Vaccination 182
182 
COVID-19 vaccine: A hope and prayer?
World of DTC Marketing
JULY 22, 2020
QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. billion for 100 million doses of a vaccine made by Pfizer Inc. The question that the media is asking is “will consumers trust a COVID-19 vaccine?” health officials agreed to pay $1.95
Vaccination 130
130 
The real motivation for COVID vaccine development
World of DTC Marketing
MARCH 15, 2021
SUMMARY : Big pharma is a big business, and nothing motivates big companies more than the potential to earn a lot of money on new products. Pfizer, alone, is estimated to earn about $15 billion for their vaccine, and they had absolutely nothing to do with Operation Warp Speed. There’s a lot of money in COVID vaccines.
Vaccination 180
180 
How pharma companies and governments can overcome COVID-19 vaccine hesitancy
BioPharma Reporter
NOVEMBER 18, 2020
While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide. The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally.
Pfizer’s vaccine results “a political conspiracy”
World of DTC Marketing
NOVEMBER 12, 2020
Pfizer did not take government money to develop a COVID vaccine and said the release of preliminary vaccine data was based on receiving the data on Monday. According to JAMA , “between January 2010 and June 2020, the FDA approved 21 vaccines, most commonly for influenza (5 [23.8%]) and meningococcus (5 [23.8%]).
Vaccination 187
187 
Can J&J’s vaccine approval erase bad pharma?
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? billion in penalties.
Vaccination 180
180 
Will people line up for a COVID-19 vaccine?
World of DTC Marketing
AUGUST 3, 2020
QUICK READ: As COVID-19 vaccines enter Phase III trials one has to wonder just how transparent pharma companies will be with the data. Personally I would want to know as much as I can before I ask for the vaccine but I also know that greed can make people do stupid things and there is a lot of money at stake here.
Vaccination 155
155 
COVID-19 vaccine equity: Campaigners say onus on pharma companies to start sharing IP and to transfer technology
BioPharma Reporter
FEBRUARY 2, 2021
Rows about vaccine supply and threats of export blocks donât do anything to bring us closer to ending the COVID-19 pandemic, say campaigners pushing for vaccine equity on a global level.
Blaming the anti-vaxxers is not the answer
World of DTC Marketing
JULY 26, 2021
There are many reasons why people aren’t getting vaccinated. Pharma companies should ensure that product content also contains health information to address chronic conditions. Until we have more data to really understand why people are getting vaccinated against COVID, we shouldn’t fall into the trap of blame.
Vaccination 319
319 
Large pharma companies support Women in STEM leadership pilot
Drug Discovery World
DECEMBER 7, 2022
We are excited to open up the waitlist for the next stage, and encourage people from other backgrounds to get involved, including our tech company members.” . The programme is like a vaccine – we expose leaders to trial situations to understand the root causes of how inequality manifests in the workplace and to uncover unconscious biases.
Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .
Packaging 130
130 
GSK flags new data suggesting a stark decline in routine adult vaccinations in the US
BioPharma Reporter
MARCH 23, 2021
The pharma company and the CDC are recommending that adults continue routine vaccination during the COVID-19 pandemic to reduce future vaccine-preventable disease (VPD) outbreaks and overall strain on the healthcare system.
Vaccination 105
105 
UK Pharma Company Scancell Selects COVID-19 Vaccine for Clinical Trials | 2020-12-21
The Pharma Data
DECEMBER 20, 2020
UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.
UK Vaccine Taskforce head lifts lid on Novavax deal
pharmaphorum
APRIL 19, 2021
The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . It is really important and we have seen a lot of pharma companies interested in the UK. Speed is everything in clinical development.
Vaccination 141
141 
Sanofi to Manufacture Vaccines in Saudi Arabia, Signs MoU
Pharmaceutical Commerce
JULY 7, 2023
Pharma company will produce seven vaccines, as nation aims to strengthen status as a life sciences hub.
Vaccination 52
52 
GSK’s Maria Reyes Boceta-Muñoz Talks Vaccine Development in a Post-Pandemic World
XTalks
SEPTEMBER 5, 2023
Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?
Vaccination 96
96 
Cancer vaccines: providing the edge in oncology
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.
Vaccination 123
123 
Cyberattack targets EMA, hacks COVID-19 vaccine data
pharmaphorum
DECEMBER 10, 2020
The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed. Shortly after however BioNTech confirmed that documents submitted as part of its marketing application for coronavirus vaccine BNT-162b had been accessed by the hackers.
Vaccination 109
109 
Report suggests UK’s national vaccine facility is on the block
pharmaphorum
NOVEMBER 29, 2021
The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.
Vaccination 88
88 
Novartis tightens up its COVID-19 vaccine policy for staff
pharmaphorum
OCTOBER 3, 2021
Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites. Novartis joins a lengthening list of pharma companies that are mandating full vaccination – at least in some developed countries like the US.
Vaccination 104
104 
The supply chain innovations behind the world’s largest vaccine programme
Pharmaceutical Technology
DECEMBER 13, 2022
To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date. Before the COVID-19 pandemic, 25-50% of vaccines were wasted due to cold chain issues. Free Report.
Vaccination 130
130 
Keeping the pandemic at bay with needle-free vaccine delivery
pharmaphorum
SEPTEMBER 20, 2022
Ben Hargreaves highlights the innovation in vaccine delivery that could make a difference in providing low- and middle-income countries with vaccination options, as well as offer a boost to programs in higher-income countries. The question to be answered in the future will be how to improve upon existing vaccine technology.
Vaccination 90
90 
Moderna unveils $500m plan for African vaccine facility
pharmaphorum
OCTOBER 7, 2021
Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.
Vaccination 86
86 
COVID prompts another milestone, as India clears first DNA vaccine
pharmaphorum
AUGUST 23, 2021
The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.
DNA 98
98 
Boris Johnson slammed for saying “greed” is behind UK vaccine success
pharmaphorum
MARCH 24, 2021
The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme, before backtracking after realising he had made a blunder and telling attendees to forget the comments. " But he’s wrong.
Vaccination 107
107 
Recipharm leverages BSF capabilities at French site, secures vaccine packaging deal
BioPharma Reporter
JANUARY 28, 2022
Contract development and manufacturing organization (CDMO), Recipharm, says it has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.
Packaging 52
52 
The Covid cash cow – a look at the Covid vaccine sales figures
pharmaphorum
NOVEMBER 19, 2021
The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. Meanwhile, China and Russia have rolled out state-owned vaccines. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year.
Sales 130
130 
Boosting COVID-19 vaccines supplies: EU concludes exploratory talks with Valneva
BioPharma Reporter
JANUARY 12, 2021
The European Commission had held discussions with French pharma company, Valneva, with a view to securing up to 60 million doses of its inactivated virus COVID-19 vaccine, VLA2001.
Vaccination 64
64 
Let's personalize your content